Seeking Alpha

  Threshold Pharmaceuticals, Inc. (THLD) - NASDAQ

  • The Scientist | Send Message 13 Sep 2012

    THLD CEO at Stifel Nicolaus presentation stated OS data for ESMO abstract 9/17 will be 'subtlety different' than mature data on 9/29
      THLD vs. ETF Alternatives
      Company Description
      Threshold Pharmaceuticals, Inc. is a biotechnology company. It focuses on the discovery and development of drugs targeting the microenvironment of solid tumors as novel treatments for patients living with cancer.
      Sector: Healthcare
      Industry: Biotechnology
      Country: United States